Autres langues NATCO Pharma Limited

Actions

NATCOPHARM

INE987B01026

Temps Différé NSE India S.E. Autres places de cotation 12:26:49 05/06/2024			Varia. 5j.	Varia. 1 janv.
1 015 ^INR	+4,62 %		-2,50 %	+25,12 %

28/05	ACTIONS INDIENNES - Les métaux et les valeurs pharmaceutiques tirent les indices indiens vers le haut	RE
28/05	Transcript : NATCO Pharma Limited, Q4 2024 Earnings Call, May 28, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Delhi High Court Refuses To Vacate Interim Injunction Granted In Favour Of Novartis For Compound Ceritinib	30/05
INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher	28/05
Patent Infringement In India: Recent Case Studies And Legal Updates	27/05
NATCO Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	27/05
NATCO Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	27/05
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	08/05
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	08/05
AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement	08/05
Natco Pharma Gets US FDA Warning Letter after Inspection of Kothur, India Unit	09/04
NATCO Pharma Limited Announces Board Appointments	27/03
INDIA STOCKS-Indian shares erase early gains, weighed down by IT stocks	19/02
NATCO Pharma Limited Revises Earnings Guidance for the Fiscal Year 2024	15/02
Corporate Action-Board Approves Third Interim Dividend for the Financial Year 2023-24, Payable on 4 March 2024	14/02
NATCO Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	14/02
Cellogen Therapeutics announced that it has received $2 million in funding from NATCO Pharma Limited	17/01
Floods Disrupt Operations of Natco Pharma's Plant in Tamil Nadu, India	07/12
Natco Pharma's Consolidated Profit Soars in Fiscal Q2, Declares Second Interim Dividend	14/11
NATCO Pharma Limited Declares Second Interim Dividend for the Financial Year 2023-24, Payable on 1 December, 2023	14/11
NATCO Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	14/11
US FDA Clears Natco Pharma's Pharmacovigilance Department in Hyderabad, India	02/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues NATCO Pharma Limited

Actions

NATCOPHARM

INE987B01026

Autres langues

Filtres